Anika Therapeutics Inc. · NASDAQ:ANIK
Caligan Partners LP reported a 9.95% stake in Anika Therapeutics Inc. (Schedule 13D/A)
Event Jan 23, 2026 · Filed Jan 27, 2026
Caligan Partners LP reported a 9.95% stake in Anika Therapeutics Inc., 1,435,130 shares, with active intent on Jan 23, 2026. Filed Jan 27, 2026 (Schedule 13D/A).
- Stake
- 9.95%
- Shares
- 1,435,130
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Caligan Partners LP | 9.95% | 1,435,130 |
| David Johnson | 9.95% | 1,435,130 |
Source
Related
- Anika Therapeutics Inc.
- Caligan Partners LP
- Anika Therapeutics Inc. shareholders
- Schedule 13D/A · Caligan Partners LP · Nov 21, 2025
- Form 4 · Fischetti Gary P · Aug 5, 2026
- Schedule 13G/A · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · BlackRock Portfolio Management LLC · Jul 17, 2026
- Form 4 · Fischetti Gary P · Jun 23, 2026
- Form 4 · Henneman John B III · Jun 23, 2026